
Canada · Professional training & coaching startup
NEXT Integrative Minds Life Sciences Ltd.
Funding reportedLast round: Seed
NEXT Integrative Minds Life Sciences Ltd.
(NEXT) is a life sciences and technology company dedicated to enhancing neuro-literacy, which is the understanding of brain function and how to optimize it. The company operates MYNEXTCommunity.com and has developed the NEXT SystemTM, a cloud-based platform that provides access to neuroscience-based tools aimed at improving personal performance, well-being, and lifelong learning. NEXT's mission is to empower individuals and organizations to overcome mental barriers that hinder performance and creativity. The company utilizes a structured methodology called the Universal Method for Applied Neuro-literacyTM, which is based on extensive neuroscience research. This method helps users rewire counterproductive brain patterns and adopt more effective thinking habits. The NEXT SystemTM serves as a versatile platform for both personal development and as a resource for thought leaders and organizations to create and share evidence-based neuro-literacy products. NEXT offers various services, including neuro-literacy training programs, ongoing support, and resources for users to develop their own programs. The platform is designed to be accessible to a wide audience, including individuals seeking personal growth and organizations looking to enhance employee training and innovation.
Funding, as reported
What they build
Known for
information technology & servicesb2csaasfamiliy performance wellbeingservicesneuroliteracybased designworkplace performance wellbeingcomputer softwareb2b
Built with from their website
AtlassianAtlassian CloudTwilio SendGrid Email Marketing CampaignsMicrosoft ExchangeMicrosoft 365 Apps & ServicesMailJetAmazon Route 53Amazon AWSSendgridMicrosoft Exchange Online
Microsoft 365AWS CloudOutlookMicrosoft Email ProvidersTwilio SendGrid Email APIGoogle Search Console
Add your raise, your deck and your story, and put NEXT Integrative Minds Life Sciences in front of investors. Or tell us what we have wrong.